Drugs / Bupropion XL
last change Aug 2020 re-read 3 minutes ago

Bupropion XL

Developed for
bipolar I disorder · major depressive disorder

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy3 trials
Phase 3 NCT00958633 Comparator Nov 2010 → Mar 2020 bipolar I disorder University of British Columbia Terminated No outcome recorded Stop: Enrollment
Phase 4 NCT02332291 Comparator Apr 2015 → Aug 2020 major depressive disorder Vanderbilt University Medical Center Completed No outcome recorded
— NCT01488266 Comparator Nov 2011 → Jan 2013 major depressive disorder Korea University Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as bupropion XL “bupropion XL” NCT01488266 ↗
2

NCT02332291 ↗

NCT00958633 ↗